BLOCKING MONOCLONAL-ANTIBODIES TO ALPHA-V-BETA-3 INTEGRIN - A UNIQUE EPITOPE OF ALPHA-V-BETA-3 INTEGRIN IS PRESENT ON HUMAN OSTEOCLASTS

被引:38
作者
CHUNTHARAPAI, A
BODARY, S
HORTON, M
KIM, KJ
机构
[1] GENENTECH INC,S SAN FRANCISCO,CA 94080
[2] ST BARTHOLOMEWS HOSP,ICRF,HAEMOPOEISIS RES GRP,LONDON EC1A 7BE,ENGLAND
关键词
D O I
10.1006/excr.1993.1096
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Integrins are a family of cell surface glycoproteins that promote cell adhesion. The integrin αVβ3, vitronectin receptor, is a major integrin expressed by osteoclasts. To further investigate the role of αVβ3 in cell adhesion, we generated and characterized monoclonal antibodies to αVβ3 by immunizing BALB/c mice with purified αVβ3 protein. Three monoclonal antibodies (mAbs), 9D4.9. 1, 9G2.1.3, and 10C4.1.3, from a total of more than 1100 positive cultures which bound αVβ3, were characterized extensively: mAbs 9G2.1.3 and 10C4.1.3 recognize the αVβ3 complex whereas mAb 9D4.9.1 reacts with the β3-chain shared between the αVβ3 complex and gpIIbIIIa. Further epitope mapping using flow microfluorometry analysis and histochemical staining of various tissues showed that 9D4.9.1 and 10C4.1.3 recognized distinct epitopes. Ligand-binding studies using cell-bound and purified αVβ3 demonstrated that all three mAbs blocked fibrinogen binding. Vitronectin binding was blocked by mAb 9D4.9.1 and, less effectively, by mAb 10C4.1.3; mAb 9G2.1.3 was without effect. All three mAbs recognized osteoclasts from human tissues; mAb 9G2.1.3 also stained osteoclasts from a wide range of nonhuman species. Monoclonal antibodies 9D4.9.1 and 9G2.1.3 bound to a panel of cultured cell lines and various tissues. In contrast, mAb 10C4.1.3 bound only weakly or not at all to tissues expressing αVβ3 with the exception of osteoclasts. Thus, mAb 10C4.1.3 showed a very narrow tissue specificity being restricted to high-level expression on human osteoclasts. © 1993 Academic Press, Inc.
引用
收藏
页码:345 / 352
页数:8
相关论文
共 50 条
  • [1] ALBELDA SM, 1990, CANCER RES, V50, P6757
  • [2] NEW SITES OF CELLULAR VITRONECTIN RECEPTOR IMMUNOREACTIVITY DETECTED WITH OSTEOCLAST-REACTING MONOCLONAL-ANTIBODIES 13C2 AND 23C6
    ATHANASOU, NA
    QUINN, J
    HORTON, MA
    MCGEE, JOD
    [J]. BONE AND MINERAL, 1990, 8 (01): : 7 - 22
  • [3] CYCLIC RGD PEPTIDE ANALOGS AS ANTIPLATELET ANTITHROMBOTICS
    BARKER, PL
    BULLENS, S
    BUNTING, S
    BURDICK, DJ
    CHAN, KS
    DEISHER, T
    EIGENBROT, C
    GADEK, TR
    GANTZOS, R
    LIPARI, MT
    MUIR, CD
    NAPIER, MA
    PITTI, RM
    PADUA, A
    QUAN, C
    STANLEY, M
    STRUBLE, M
    TOM, JYK
    BURNIER, JP
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (11) : 2040 - 2048
  • [4] BODARY SC, 1989, J BIOL CHEM, V264, P18859
  • [5] BODARY SC, 1990, J BIOL CHEM, V265, P5938
  • [6] BOUKERCHE H, 1989, BLOOD, V74, P909
  • [7] STRUCTURE, FUNCTION AND BIOLOGICAL PROPERTIES OF INTEGRIN ALPHA-V-BETA-3 ON HUMAN-MELANOMA CELLS
    CHERESH, DA
    [J]. CANCER AND METASTASIS REVIEWS, 1991, 10 (01) : 3 - 10
  • [8] A NOVEL VITRONECTIN RECEPTOR INTEGRIN (ALPHA-V-BETA-X) IS RESPONSIBLE FOR DISTINCT ADHESIVE PROPERTIES OF CARCINOMA-CELLS
    CHERESH, DA
    SMITH, JW
    COOPER, HM
    QUARANTA, V
    [J]. CELL, 1989, 57 (01) : 59 - 69
  • [9] CHERESH DA, 1987, J BIOL CHEM, V262, P17703
  • [10] THE OSTEOCLAST FUNCTIONAL ANTIGEN, IMPLICATED IN THE REGULATION OF BONE-RESORPTION, IS BIOCHEMICALLY RELATED TO THE VITRONECTIN RECEPTOR
    DAVIES, J
    WARWICK, J
    TOTTY, N
    PHILP, R
    HELFRICH, M
    HORTON, M
    [J]. JOURNAL OF CELL BIOLOGY, 1989, 109 (04) : 1817 - 1826